These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 7937155)

  • 21. Sequence-independent inhibition of in vitro vascular smooth muscle cell proliferation, migration, and in vivo neointimal formation by phosphorothioate oligodeoxynucleotides.
    Wang W; Chen HJ; Schwartz A; Cannon PJ; Stein CA; Rabbani LE
    J Clin Invest; 1996 Jul; 98(2):443-50. PubMed ID: 8755655
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phosphorothioate-phosphodiester oligonucleotide co-polymers: assessment for antisense application.
    Ghosh MK; Ghosh K; Cohen JS
    Anticancer Drug Des; 1993 Feb; 8(1):15-32. PubMed ID: 8386513
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transformed and immortalized cellular uptake of oligodeoxynucleoside phosphorothioates, 3'-alkylamino oligodeoxynucleotides, 2'-O-methyl oligoribonucleotides, oligodeoxynucleoside methylphosphonates, and peptide nucleic acids.
    Gray GD; Basu S; Wickstrom E
    Biochem Pharmacol; 1997 May; 53(10):1465-76. PubMed ID: 9260874
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nucleotide pyrophosphatase/phosphodiesterase 1 is responsible for degradation of antisense phosphorothioate oligonucleotides.
    Wójcik M; Cieślak M; Stec WJ; Goding JW; Koziołkiewicz M
    Oligonucleotides; 2007; 17(1):134-45. PubMed ID: 17461770
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantitation of the binding, uptake, and degradation of fluoresceinylated neoglycoproteins by flow cytometry.
    Midoux P; Roche AC; Monsigny M
    Cytometry; 1987 May; 8(3):327-34. PubMed ID: 3109859
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interactions of antisense DNA oligonucleotide analogs with phospholipid membranes (liposomes).
    Akhtar S; Basu S; Wickstrom E; Juliano RL
    Nucleic Acids Res; 1991 Oct; 19(20):5551-9. PubMed ID: 1945832
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Triple helix formation with purine-rich phosphorothioate-containing oligonucleotides covalently linked to an acridine derivative.
    Lacoste J; François JC; Hélène C
    Nucleic Acids Res; 1997 May; 25(10):1991-8. PubMed ID: 9115367
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of cooperative PS-oligo activation of human TLR9.
    Pollak AJ; Zhao L; Crooke ST
    Mol Ther Nucleic Acids; 2023 Sep; 33():832-844. PubMed ID: 37675184
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Kinetics and thermodynamics of i-DNA formation: phosphodiester versus modified oligodeoxynucleotides.
    Mergny JL; Lacroix L
    Nucleic Acids Res; 1998 Nov; 26(21):4797-803. PubMed ID: 9776737
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro antigene therapy targeting HPV-16 E6 and E7 in cervical carcinoma.
    Madrigal M; Janicek MF; Sevin BU; Perras J; Estape R; Peñalver M; Averette HE
    Gynecol Oncol; 1997 Jan; 64(1):18-25. PubMed ID: 8995542
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lipophilic pro-oligonucleotides are rapidly and efficiently internalized in HeLa cells.
    Vivès E; Dell'Aquila C; Bologna JC; Morvan F; Rayner B; Imbach JL
    Nucleic Acids Res; 1999 Oct; 27(20):4071-6. PubMed ID: 10497272
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The influence of polarized epithelial (Caco-2) cell differentiation on the cellular binding of phosphodiester and phosphorothioate oligonucleotides.
    Akhtar S; Beck GF; Hawley P; Irwin WJ; Gibson I
    Antisense Nucleic Acid Drug Dev; 1996; 6(3):197-206. PubMed ID: 8915504
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phosphorothioate Oligodeoxynucleotide Inhibition of Restenosis.
    Rabbani LE; Wang W
    J Thromb Thrombolysis; 1998 May; 5(2):125-128. PubMed ID: 10767106
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comparison of guanosine-quartet inhibitory effects versus cytidine homopolymer inhibitory effects on rat neointimal formation.
    Wang W; Chen HJ; Sun J; Benimetskaya L; Schwartz A; Cannon P; Stein CA; Rabbani LE
    Antisense Nucleic Acid Drug Dev; 1998 Jun; 8(3):227-36. PubMed ID: 9669660
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enzymatic assignment of diastereomeric purity of stereodefined phosphorothioate oligonucleotides.
    Koziołkiewicz M; Owczarek A; Gendaszewska E
    Antisense Nucleic Acid Drug Dev; 1999 Apr; 9(2):171-81. PubMed ID: 10355823
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Binding, uptake, and intracellular trafficking of phosphorothioate-modified oligodeoxynucleotides.
    Beltinger C; Saragovi HU; Smith RM; LeSauteur L; Shah N; DeDionisio L; Christensen L; Raible A; Jarett L; Gewirtz AM
    J Clin Invest; 1995 Apr; 95(4):1814-23. PubMed ID: 7706488
    [TBL] [Abstract][Full Text] [Related]  

  • 37. p53 interference and growth inhibition in p53-mutant and overexpressing endometrial cancer cell lines.
    Janicek MF; Angioli R; Unal AD; Sevin BU; Madrigal M; Estape R; Averette HE
    Gynecol Oncol; 1997 Jul; 66(1):94-102. PubMed ID: 9234928
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intracellular disposition and metabolism of fluorescently-labeled unmodified and modified oligonucleotides microinjected into mammalian cells.
    Fisher TL; Terhorst T; Cao X; Wagner RW
    Nucleic Acids Res; 1993 Aug; 21(16):3857-65. PubMed ID: 8396239
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanistic aspects of the interaction of polyanionic oligodeoxynucleotides with HL60 cells.
    Stein CA; Tonkinson J; Gervasoni J; Zhang LM; Krishna S; Taub R; Fields S; Delohery T; Rotenberg S
    Ann N Y Acad Sci; 1992 Oct; 660():313-4. PubMed ID: 1340143
    [No Abstract]   [Full Text] [Related]  

  • 40. Toxicologic effects of an oligodeoxynucleotide phosphorothioate and its analogs following intravenous administration in rats.
    Agrawal S; Zhao Q; Jiang Z; Oliver C; Giles H; Heath J; Serota D
    Antisense Nucleic Acid Drug Dev; 1997 Dec; 7(6):575-84. PubMed ID: 9450915
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.